Comparative modeling of gastric cancer disparities and prevention in the US and globally

美国和全球胃癌差异和预防的比较模型

基本信息

  • 批准号:
    10705668
  • 负责人:
  • 金额:
    $ 81.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-15 至 2026-08-31
  • 项目状态:
    未结题

项目摘要

Gastric cancer (GC), specifically gastric adenocarcinoma, is the fifth most common cancer and the third leading cause of cancer death globally and has been categorized as a neglected cancer by the World Health Organization. In the U.S., there are stark disparities, with Blacks, Hispanics and Asians having a nearly two- fold greater risk of developing or dying from GC compared to Whites, reflecting differences in risk factors, such as Helicobacter pylori (H. pylori) infection and smoking, as well as access to primary prevention and care. Several factors are changing the landscape of GC prevention, including a better understanding of the disease natural history, new evidence on prevention from prospective studies, and anticipated results from randomized controlled trials. As early GC detection can improve survival by allowing for curative surgical or noninvasive endoscopic resection, new targeted approaches to GC prevention have the potential to markedly improve population health and reduce GC disparities within the U.S. Although H. pylori has been the primary focus of global GC prevention efforts to date, substantial variation by subpopulation in H. pylori prevalence in the U.S. and the world has accentuated the need to optimize H. pylori screen-and-treat interventions for vulnerable groups. One approach is targeted endoscopic screening of high-risk individuals. For instance, persons found to have gastric intestinal metaplasia, a precursor lesion associated with a high progression risk to gastric neoplasia, are recommended to undergo endoscopic surveillance in many countries. A critical need exists to identify effective and cost-effective strategies to address these clinical challenges in the U.S., as well as globally. This proposed work builds upon prior GC work spanning GC and H. pylori simulation modeling studies, GC secondary database analyses, and relevant methodologic and global cancer modeling publications. The research team for this proposal has a vast collective experience in simulation and comparative modeling for cancer control, clinical expertise across the spectrum of GC prevention and care, and a demonstrated track record and commitment to informing cancer care and policy. The proposed three modeling groups are well-positioned to perform and successfully complete the highly relevant project aims. The overarching goal of the proposed research is to produce innovative and paradigm-shifting changes to cancer care through a disparities-focused modeling approach targeting the most vulnerable, high-risk populations that bear the greatest burden of GC in the US, and the world. We will accomplish this goal by performing comparative modeling and completing the following aims: 1) Develop GC simulation models to estimate GC outcomes for subgroups by race and ethnicity in the U.S.; 2) Assess the impact of risk factor trends and primary prevention strategies on GC disparities; 3) Evaluate targeted secondary prevention strategies for reducing early onset-related mortality and GC disparities, and 4) Adapt the models to evaluate GC prevention policies in the global setting.
胃癌(GC),特别是胃腺癌,是第五种最常见的癌症,第三种最常见的癌症

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Gastric Cancer:: An Update on the Rapidly Changing Characteristics and Evolving Opportunities for Interventions.
胃癌:快速变化的特征和不断变化的干预机会的最新情况。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Chin Hur其他文献

Chin Hur的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Chin Hur', 18)}}的其他基金

Domain-Knowledge Informed Deep Learning for Early Detection of Pancreatic Cancer
基于领域知识的深度学习用于胰腺癌的早期检测
  • 批准号:
    10458067
  • 财政年份:
    2021
  • 资助金额:
    $ 81.02万
  • 项目类别:
Comparative modeling of gastric cancer disparities and prevention in the US and globally
美国和全球胃癌差异和预防的比较模型
  • 批准号:
    10330855
  • 财政年份:
    2021
  • 资助金额:
    $ 81.02万
  • 项目类别:
Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype
按基因型分类的林奇综合征最佳结直肠癌监测策略
  • 批准号:
    10674701
  • 财政年份:
    2021
  • 资助金额:
    $ 81.02万
  • 项目类别:
Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype
按基因型分类的林奇综合征最佳结直肠癌监测策略
  • 批准号:
    10458721
  • 财政年份:
    2021
  • 资助金额:
    $ 81.02万
  • 项目类别:
Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype
按基因型分类的林奇综合征最佳结直肠癌监测策略
  • 批准号:
    10298217
  • 财政年份:
    2021
  • 资助金额:
    $ 81.02万
  • 项目类别:
Domain-Knowledge Informed Deep Learning for Early Detection of Pancreatic Cancer
基于领域知识的深度学习用于胰腺癌的早期检测
  • 批准号:
    10317236
  • 财政年份:
    2021
  • 资助金额:
    $ 81.02万
  • 项目类别:
A Personalized Approach to Targeted Esophageal Cancer Screening
针对性食管癌筛查的个性化方法
  • 批准号:
    10212990
  • 财政年份:
    2020
  • 资助金额:
    $ 81.02万
  • 项目类别:
A Personalized Approach to Targeted Esophageal Cancer Screening
针对性食管癌筛查的个性化方法
  • 批准号:
    10661535
  • 财政年份:
    2020
  • 资助金额:
    $ 81.02万
  • 项目类别:
A Personalized Approach to Targeted Esophageal Cancer Screening
针对性食管癌筛查的个性化方法
  • 批准号:
    10413908
  • 财政年份:
    2020
  • 资助金额:
    $ 81.02万
  • 项目类别:
Controlling Esophageal Cancer: A Collaborative Modeling Approach
控制食管癌:协作建模方法
  • 批准号:
    9753971
  • 财政年份:
    2018
  • 资助金额:
    $ 81.02万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 81.02万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 81.02万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 81.02万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 81.02万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 81.02万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 81.02万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 81.02万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 81.02万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 81.02万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 81.02万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了